AMR Alliance Japan (Secretariat: Health and Global Policy Institute) held a meeting to discuss its FY2022 plans among Alliance members.

AMR Alliance Japan, as an independent platform for multisector discussion with the mission of contributing to the improvement of public health by promoting measures on AMR, will continue to work with Alliance members and partner organizations to deepen policy debate around AMR.

In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.

■Overview
Date and time: Monday, December 6, 2021
Organizer: AMR Alliance Japan (Secretariat: HGPI)

■Discussion
Participants (alphabetical order by last name):
Kazuyuki Akai (Director, Business Development, Nippon Becton Dickinson Company Ltd.)
Kyoko Ama (Representative, Children and Healthcare Project)
Tetsuo Asai (Chariman, Japanese Society of Antimicrobials for Animals/ Professor, Joint Graduate School of Veterinary Sciences, Gifu University)
Hirotake Fukumoto (Director, Community Medical Division, Health and Welfare Bureau, Himeji City）
Midori Hirai (Chair, Pharmaceutical Education Committee, The Pharmaceutical Society of Japan / Director, Japanese Red Cross Hyogo Blood Center)
Hiroshi Itoh (Internal Medicine, Medical Affairs, Pfizer Japan Inc.)
Satoshi Kamayachi (Executive Board Member, Japan Medical Association)
Testuya Matsumoto (President, Japanese Society of Chemotherapy / Chief Professor, Department of Infectious Diseases, International University of Health and Welfare Graduate School of Medicine)
Choichiro Miyazaki (Vice Chairman, Japan Pharmaceutical Association)
Yuichi Muraki (Representative, Japanese Society of Pharmaceutical Health Care and Sciences / Professor, Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University)
Akio Ozaki (Director, Public and Industry Policy, Health Policy, MSD K. K.)
Kazunobu Ouchi (President, Japanese Society for Pediatric Infectious Diseases / Specially Appointed Professor, Department of Medical Welfare for Children, Faculty of Health and Welfare, Kawasaki University of Medical Welfare / Specially Appointed Manager, Kawasaki Medical School General Medical Center / Professor emeritus, Kawasaki Medical School)
Shougo Oosaki (Deputy Director, Community Medicine Division, Health and Welfare Bureau, Himeji City）
Toshiyuki Sakaeda (President, The Japanese Society of Therapeutic Drug Monitoring / Professor, Department of Pharmacokinetics, Kyoto Pharmaceutical University)
Kazutoshi Shibuya (President, The Japanese Society for Medical Mycology / Professor, Department of Surgical Pathology, Toho University)
Kazuhiro Tateda (President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
Yasunori Tawaragi (Director, AMR Incentives and Advocacy TF, Japan Pharmaceutical Manufacturers Association)

Moderator:
Tomohito Shibata (Manager, Health and Global Policy Institute)